Online Journal
Front Page 
 Special Reports
 News Media
 Elections & Voting
 Social Security
 Editors' Blog
 Reclaiming America
 The Splendid Failure of Occupation
 The Lighter Side
 The Mailbag
 Online Journal Stores
 Official Merchandise
 Join Mailing List

Health Last Updated: Jun 28th, 2010 - 00:33:44

University of Miami scandal raises questions about government research
By Martha Rosenberg
Online Journal Contributing Writer

Jun 28, 2010, 00:26

Email this article
 Printer friendly page

Some say the incident in which the director of the National Institute of Mental Health (NIMH) assured the University of Miami�s medical school dean if he hired Charles Nemeroff, MD, the disgraced researcher, Nemeroff could still pull in government grants is an example of the Old Boy�s Network.

NIMH director Thomas Insel, MD, assured Pascal Goldschmidt, MD, UM�s medical school dean that Nemeroff�s congressional investigation for unreported drug industry income and NIH�s termination of his $9 million grant shouldn�t stop the government funding spigot -- even as Insel personally revised NIMH�s �conflict of interest� rules.

(And even as Nemeroff serves on two NIH peer-review advisory panels that decide what? Who receives grant money.)

Insel presumably �owed� Nemeroff because the former head of psychiatry at Emory got Insel a gig there when he lost his NIH position in 1994 and helped Insel�s comeback in 2002 as NIMH director, says the Chronicle of Higher Learning. Nice revolving doors if you can catch them.

But others say it�s an example of the Old Girl�s Network since it was UM President Donna Shalala, former Health and Human Services secretary, who allowed the hiring of the poster boy for conflicts of interest without a job posting, national search, search committee or vote from UM�s psychiatry faculty.

Nor was Sen. Charles Grassely (R-Iowa), whose investigations found Nemeroff failed to disclose $1 million in drug industry income while doing �impartial� government research, amused by a Goldschmidt quote in the Chronicle that dismisses a freeze on Nemeroff-initiated grants at Emory as due to �political pressure.�

(Nemeroff research found the tardive dyskinesia producing Abilify had �excellent� safety.)

While many dispute Nemeroff�s character -- he did �science pimping for Paxil,� Bernard Carroll, MD, former psychiatry head at Duke told the Miami Herald.

�I�m not sure if I�d be around today if it weren�t for him,� Tom Johnson, former CNN network president and a Nemeroff patient, also told the Herald.

Few dispute UM�s dire financial straits.

To further Goldschmidt�s ambition to make the University of Miami �a destination facility, attracting patients from Latin America and the United States, just like Mayo and Cleveland clinics,� according to the Herald, UM bought a private hospital, two new research buildings and hired hundreds of new medical school faculty members in a $1 billion spending binge some call shadowy. It bought Cedars Medical Center, now University of Miami Hospital, from The Healthcare Company -- a firm convicted of Medicare and Medicaid fraud in 2003 -- for $270 million though the facility only earned $987,000 in profit during its last year. And there are questions about double-billing the government for patients UM clinicians see at the public Jackson Memorial Hospital swirl.

Nemeroff�s department also oversees UM Behavioral Health�s multi-million dollar Medicaid contract which embraces 900 providers, 30 hospitals and 100 community mental health centers, despite his track record with Health and Human Services.

Meanwhile new faculty recruits have left abruptly, major donors have rescinded gifts and morale at the medical school is at an all time low.

Of course Nemeroff�s hire as head of UM psychiatry looks like an unvarnished ploy to divert taxpayer dollars from the $1.4 billion NIMH budget to a private institution, courtesy of I-scratch-your-back-you-scratch-mine cronyism. But it also raises questions about how government officials trusted with public funds even got there.

�There has always been some confusion . . . about whether Yerkes [Yerkes National Primate Research Center] is part of Emory or part of the federal government,� Insel told Emory magazine as he hop-scotched between the two employers with the help of his buddy Nemeroff (doing Lord knows what to 3,400 primates.) �This is not in any way, shape, or form a federal laboratory. . . . It is, from top to bottom, part of Emory. Every brick, every animal in this place, is part of Emory University.�

No kidding. It is just this �confusion� between public and private monies -- the Yerkes Center is NIH funded, hello? -- that earned Nemeroff his ethical cloud and now Insel�s support of him as UM financial savior.

Martha Rosenberg is a Chicago columnist/cartoonist who writes about public health. She may be reached at

Copyright © 1998-2007 Online Journal
Email Online Journal Editor

Top of Page

Latest Headlines
The rise and fall of Provigil -- Part II
The rise and fall of Provigil � Part I
FL doctors tell Attorney General Bill McCollum that the lawsuit puts politics before patients
Risky drug ads raise awareness and insurance rates
Is meat and milk from clones in the food supply?
America�s mental illness epidemic: It turns out that the drugs are the problem
Noma -- The face of poverty
Army suicide report ignores suicide-producing drugs
Strontium and osteoporosis II: On our own
Is Pfizer the BP of drug companies?
University of Miami scandal raises questions about government research
Has psychiatry become unhinged? This doctor says yes
No free pens but pharma influence still felt at psychiatric meeting
Medical conference looks at rebalancing pharmaceutical industry influence
We�re all on Prozac now
Patients reported fractures caused by bone drug long before health industry
Pushing WellPoint back to nonprofit?
Thanks for nothing, Mr. �Health Care Reform� President
Who is the thief?
Should women take hormone therapy? We asked an expert